About Phylagen
Phylagen is a company based in San Francisco (United States) founded in 2014 by Jessica Green. It operates as a B2B. Phylagen has raised $14 million across 1 funding round from investors including 3M, Western Digital and Western Technology Investment. The company has 44 employees as of December 31, 2021. Phylagen operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and Pendulum, among others.
- Headquarter San Francisco, United States
- Employees 44 as on 31 Dec, 2021
- Founders Jessica Green
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Phylagen, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14 M (USD)
in 1 rounds
-
Latest Funding Round
$14 M (USD), Series A
Feb 14, 2019
-
Investors
3M
& 11 more
-
Employee Count
44
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Phylagen
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Phylagen
Phylagen has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series A round of $14 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $14.0M
-
First Round
First Round
(14 Feb 2019)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Series A - Phylagen | Valuation | Cultivian Sandbox , Breakout Ventures |
Investors in Phylagen
Phylagen has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include 3M, Western Digital and Western Technology Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage investments in science-driven companies are made.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors
|
Founded Year | Domain | Location |
Investments & Acquisitions by Phylagen
Financial Statements - Phylagen
Phylagen Comparisons
Competitors of Phylagen
Phylagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and Pendulum, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| domain | founded_year | HQ Location |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
Frequently Asked Questions about Phylagen
Phylagen was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Phylagen is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Phylagen is a funded company, having raised a total of $14M across 1 funding round to date. The company's 1st funding round was a Series A of $14M, raised on Feb 14, 2019.
As of Dec 31, 2021, the latest employee count at Phylagen is 44.
Phylagen delivers comprehensive genome sequencing solutions for microbial analysis through advancing biotech innovations, focusing on genomic solutions, microbial analysis, and sequencing technology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Phylagen's top competitors include Visby Medical, Inflammatix and MeMed.
Phylagen has 12 investors. Key investors include 3M, Western Digital, Western Technology Investment, Cultivian Sandbox, and Breakout Ventures.